AstraZeneca
-
People moves: Joris Silon takes over as head of IR at AstraZeneca as Dollar Tree brings in Daniel Delrosario
London-listed biopharmaceutical company AstraZeneca has brought in Joris Silon as its new head of IR, in a move effective from 1 March. Silon, who previously served as the firm’s country president for AstraZeneca US, will replace Andy Barnett, who is taking up another internal position.
